Stocks to Watch: FedEx, Kezar Life Sciences, Transcat
By Ben Glickman
FedEx said fiscal first-quarter profit rose from a year earlier and topped analysts' estimates. The shipping company's ongoing cost-cutting measures boosted margins, even as demand slipped. Shares rise 5.5% to $264.28 after hours.
Kezar Life Sciences agreed to allow Everest Medicines, a biopharmaceutical company, to develop and commercialize zetomipzomib in Greater China, South Korea and Southeast Asia. Under the agreement, Kezar may receive up to $132.5 million in total payments, plus tiered royalties. Shares rise 16% to $1.32 after hours.
Transcat said it would launch a public offering of its common stock. The industrial instruments maker didn't say how many shares it would sell, but noted it would use the proceeds to repay its credit facility, for working capital and for general corporate purposes. Shares sink 8.4% to $99.50 after hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
September 20, 2023 20:15 ET (00:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
This Cheap Stock Is Still a Buy Even After 50% Rally
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying